Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.

Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES.

J Virol. 2009 May;83(9):4652-69. doi: 10.1128/JVI.02408-08. Epub 2009 Feb 25.

2.

EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.

Saha A, Bamidele A, Murakami M, Robertson ES.

J Virol. 2011 Mar;85(5):2079-88. doi: 10.1128/JVI.02279-10. Epub 2010 Dec 22.

3.

Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.

Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES.

Virology. 2009 Jun 5;388(2):236-47. doi: 10.1016/j.virol.2009.03.027. Epub 2009 Apr 24.

4.

Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.

Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES.

PLoS Pathog. 2011 Feb 10;7(2):e1001275. doi: 10.1371/journal.ppat.1001275.

5.

Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.

Bajaj BG, Murakami M, Cai Q, Verma SC, Lan K, Robertson ES.

J Virol. 2008 Apr;82(8):4082-90. doi: 10.1128/JVI.02500-07. Epub 2008 Feb 6.

6.

An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.

Shukla SK, Jha HC, El-Naccache DW, Robertson ES.

Oncotarget. 2016 Apr 5;7(14):18116-34. doi: 10.18632/oncotarget.7502.

7.

Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.

Cai Q, Guo Y, Xiao B, Banerjee S, Saha A, Lu J, Glisovic T, Robertson ES.

PLoS Pathog. 2011 Dec;7(12):e1002418. doi: 10.1371/journal.ppat.1002418. Epub 2011 Dec 8.

8.

Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.

Knight JS, Sharma N, Robertson ES.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18562-6. Epub 2005 Dec 13.

9.

E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.

Saha A, Lu J, Morizur L, Upadhyay SK, Aj MP, Robertson ES.

PLoS Pathog. 2012;8(3):e1002573. doi: 10.1371/journal.ppat.1002573. Epub 2012 Mar 15.

10.

Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.

Pei Y, Singh RK, Shukla SK, Lang F, Zhang S, Robertson ES.

J Virol. 2018 Aug 29;92(18). pii: e00663-18. doi: 10.1128/JVI.00663-18. Print 2018 Sep 15.

PMID:
29997218
11.

Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.

Jha HC, A J MP, Saha A, Banerjee S, Lu J, Robertson ES.

J Virol. 2014 Apr;88(7):3776-88. doi: 10.1128/JVI.03568-13. Epub 2014 Jan 15.

13.

Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor.

Sahu SK, Mohanty S, Kumar A, Kundu CN, Verma SC, Choudhuri T.

Virology. 2014 Jan 5;448:333-43. doi: 10.1016/j.virol.2013.10.023. Epub 2013 Nov 12.

15.

Targeting retinoblastoma protein for degradation by proteasomes.

Ying H, Xiao ZX.

Cell Cycle. 2006 Mar;5(5):506-8. Epub 2006 Mar 1.

PMID:
16552188
16.

The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.

Banerjee S, Lu J, Cai Q, Saha A, Jha HC, Dzeng RK, Robertson ES.

PLoS Pathog. 2013;9(5):e1003314. doi: 10.1371/journal.ppat.1003314. Epub 2013 May 2.

17.

Conserved cell cycle regulatory properties within the amino terminal domain of the Epstein-Barr virus nuclear antigen 3C.

Sharma N, Knight JS, Robertson ES.

Virology. 2006 Mar 15;346(2):379-84. Epub 2005 Dec 20.

18.
19.

EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.

Banerjee S, Lu J, Cai Q, Sun Z, Jha HC, Robertson ES.

PLoS Pathog. 2014 Aug 14;10(8):e1004304. doi: 10.1371/journal.ppat.1004304. eCollection 2014 Aug.

20.

Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.

Wade M, Li YC, Matani AS, Braun SM, Milanesi F, Rodewald LW, Wahl GM.

Oncogene. 2012 Nov 8;31(45):4789-97. doi: 10.1038/onc.2011.625. Epub 2012 Jan 23.

Supplemental Content

Support Center